亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Structure-activity relationship studies and biological evaluation of selective sphingosine kinase inhibitors

作者
Emily A. Morris
出处
期刊:Virginia Tech - Virginia Tech Works [Virginia Tech]
摘要

Sphingosine 1-phosphate (S1P) has become a prevalent drug discovery target due to studies implicating it to several disease pathologies such as fibrosis, sickle cell disease, inflammation, diabetes, and cancer. S1P functions to induce cell proliferation and migration. S1P signaling occurs through intracellular targets or transport outside of the cell via ABC transporters, where it acts as a ligand to G-protein coupled receptors (S1P1-5). Sphingosine kinase (SphK) 1 and 2 phosphorylate sphingosine to S1P; these are the only enzymes known to mediate the phosphoryl transfer. Inhibiting either or both SphKs helps to modulate S1P, which may be useful as a therapeutic avenue for disease states where S1P signaling has gone awry. Herein, we document our efforts in profiling the structure-activity relationships (SAR) of SphK2 through an iterative process of synthesis and biological testing. First, an SAR structured around the head and linker region of our lead molecule, SLR080811, was performed. SLR080811 has a Ki of 1.3 µM and is 5-fold selective for SphK2. The modifications performed on SLR080811 yielded two promising inhibitors: SLP120701 (SphK2 selective with a Ki of 1.2 µM) and SLP7111228 (>200 fold selective for SphK1 with a Ki of 48 nM). In vitro studies in U937 cells yielded a decrease in S1P levels with the introduction of inhibitors. Mouse studies provided insight into the pharmacokinetic effect of our SphK2-selective inhibitors, revealing an increase in S1P levels in the blood. When in vivo studies were performed with the SphK1 selective inhibitor, S1P levels in blood decreased. These molecules provide the chemical biology tools to determine the effect of modulating S1P levels in vivo. We also focused our investigation on the tail region of the pharmacophore. From this study, SLM6031434 and SLM6041418 were discovered and both proved to be more potent and selective SphK2 inhibitors than SLR080811. SLM6031434 has a Ki of 370 nM and is 23-fold selective for SphK2. SLM6041418 has a Ki of 430 nM and is 24-fold selective for SphK2. Consistent with our previous observations, in vitro studies showed a decrease in S1P levels when inhibitor was introduced. Similarly, in vivo studies resulted in an increase of S1P levels in the blood. These compounds are positioned towards animal models of disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
搜集达人的应助被科研通管家采纳,获得10
15秒前
奔跑的应助被科研通管家采纳,获得10
15秒前
迷路飞凤完成签到,获得积分10
15秒前
16秒前
漂亮的又槐完成签到,获得积分10
36秒前
37秒前
39秒前
英俊的铭的应助被小小昌采纳,获得10
42秒前
46秒前
51秒前
噗愣噗愣地刚发芽完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
大胆紫烟完成签到,获得积分10
1分钟前
SEN完成签到,获得积分10
1分钟前
陶醉的傲霜完成签到,获得积分10
1分钟前
ccob完成签到,获得积分10
1分钟前
1分钟前
1分钟前
liujing_242022完成签到,获得积分10
1分钟前
1分钟前
dnpl完成签到,获得积分10
1分钟前
1分钟前
温婉的安彤完成签到,获得积分10
1分钟前
SEN关注了科研通微信公众号
1分钟前
自觉的猕猴桃完成签到,获得积分10
2分钟前
Orange的应助被糊涂的初柔采纳,获得10
2分钟前
2分钟前
酷酷云朵完成签到,获得积分10
2分钟前
2分钟前
369ninja的应助被科研通管家采纳,获得10
2分钟前
奔跑的应助被科研通管家采纳,获得10
2分钟前
奔跑的应助被科研通管家采纳,获得10
2分钟前
SEN发布了新的文献求助10
2分钟前
2分钟前
默默无闻完成签到 ,获得积分10
2分钟前
小小昌发布了新的文献求助10
2分钟前
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179877
求助须知:如何正确求助?哪些是违规求助? 9570060
关于积分的说明 21808221
捐赠科研通 7775626
什么是DOI,文献DOI怎么找? 3433171
关于科研通互助平台的介绍 2557308
邀请新用户注册赠送积分活动 2478846